| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.6 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |